This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Pharmaxis Future Growth
Future criteria checks 0/6
Pharmaxis's earnings are forecast to decline at 42.4% per annum while its annual revenue is expected to grow at 1.3% per year. EPS is expected to decline by 35.8% per annum.
Key information
-42.4%
Earnings growth rate
-35.77%
EPS growth rate
Pharmaceuticals earnings growth
14.9%
Revenue growth rate
1.3%
Future return on equity
n/a
Analyst coverage
Low
Last updated
28 Mar 2023
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:PMXS.F - Analysts future estimates and past financials data (AUD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
6/30/2025
16
-12
-10
-13
2
6/30/2024
22
5
-11
-5
2
6/30/2023
17
-10
-14
-7
2
12/31/2022
16
2
-12
-11
N/A
9/30/2022
18
2
-11
-11
N/A
6/30/2022
16
-2
-16
-16
N/A
3/31/2022
14
-16
-12
-12
N/A
12/31/2021
19
-12
-8
-8
N/A
9/30/2021
28
-1
5
5
N/A
6/30/2021
24
-3
2
3
N/A
3/31/2021
27
5
-2
-1
N/A
12/31/2020
22
-4
-5
-5
N/A
9/30/2020
12
-13
-11
-11
N/A
6/30/2020
13
-14
-14
-13
N/A
3/31/2020
13
-21
-13
-12
N/A
12/31/2019
13
-18
-14
-13
N/A
9/30/2019
13
-18
N/A
N/A
N/A
6/30/2019
12
-20
-21
-20
N/A
3/31/2019
7
-27
-20
-19
N/A
12/31/2018
22
-12
-4
-3
N/A
9/30/2018
21
-22
-13
-12
N/A
6/30/2018
49
6
11
12
N/A
3/31/2018
51
10
N/A
N/A
N/A
12/31/2017
37
-1
-2
-2
N/A
9/30/2017
36
7
8
9
N/A
6/30/2017
9
-18
-16
-15
N/A
3/31/2017
8
-16
-14
-13
N/A
12/31/2016
7
-16
-15
-14
N/A
9/30/2016
8
-14
N/A
-15
N/A
6/30/2016
10
-16
N/A
-12
N/A
3/31/2016
47
16
N/A
21
N/A
12/31/2015
48
14
N/A
29
N/A
9/30/2015
49
21
N/A
27
N/A
6/30/2015
47
18
N/A
22
N/A
3/31/2015
5
-34
N/A
N/A
N/A
12/31/2014
8
-38
N/A
-29
N/A
9/30/2014
5
-51
N/A
N/A
N/A
6/30/2014
9
-52
N/A
-28
N/A
3/31/2014
5
-44
N/A
N/A
N/A
12/31/2013
6
-43
N/A
-32
N/A
9/30/2013
4
-43
N/A
N/A
N/A
6/30/2013
3
-44
N/A
-35
N/A
3/31/2013
3
-41
N/A
-37
N/A
12/31/2012
2
-40
N/A
-35
N/A
9/30/2012
2
-39
N/A
-37
N/A
6/30/2012
1
-39
N/A
-38
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PMXS.F's earnings are forecast to decline over the next 3 years (-42.4% per year).
Earnings vs Market: PMXS.F's earnings are forecast to decline over the next 3 years (-42.4% per year).
High Growth Earnings: PMXS.F's earnings are forecast to decline over the next 3 years.
Revenue vs Market: PMXS.F's revenue (1.3% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: PMXS.F's revenue (1.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PMXS.F's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/06 22:41
End of Day Share Price
2023/03/09 00:00
Earnings
2022/12/31
Annual Earnings
2022/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Syntara Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.